Cargando…
Fibroblast Growth Factor 21 Predicts Short-Term Prognosis in Patients With Acute Heart Failure: A Prospective Cohort Study
BACKGROUND: Recent studies of fibroblast growth factor 21 (FGF21), first recognized as a regulator of glucose and lipid metabolism, have found that the level of in serum FGF21 is associated with the prognosis of many cardiovascular diseases, but its relationship to acute heart failure (AHF) patients...
Autores principales: | Wu, Guihai, Wu, Shenglin, Yan, Jingyi, Gao, Shanshan, Zhu, Jinxiu, Yue, Minghui, Li, Zexin, Tan, Xuerui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965840/ https://www.ncbi.nlm.nih.gov/pubmed/35369322 http://dx.doi.org/10.3389/fcvm.2022.834967 |
Ejemplares similares
-
Development and Validation of a Nomogram to Predict the 180-Day Readmission Risk for Chronic Heart Failure: A Multicenter Prospective Study
por: Gao, Shanshan, et al.
Publicado: (2021) -
6-Gingerol Alleviates Ferroptosis and Inflammation of Diabetic Cardiomyopathy via the Nrf2/HO-1 Pathway
por: Wu, Shenglin, et al.
Publicado: (2022) -
Sex Influence on Heart Failure Prognosis
por: Postigo, Andrea, et al.
Publicado: (2020) -
Psychological symptoms in Chinese nurses may be associated with predisposition to chronic disease: a cross-sectional study of suboptimal health status
por: Zhu, Jinxiu, et al.
Publicado: (2020) -
Dysnatremia is associated with increased risk of all-cause mortality within 365 days post-discharge in patients with atrial fibrillation without heart failure: A prospective cohort study
por: Zhou, Yan, et al.
Publicado: (2022)